3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
2
Active not recruiting
2
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Hematologic Neoplasms
2
Smoking Cessation
1
Obesity-Related Malignant Neoplasm
1
Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
fludarabine
6
trametinib
5
Specimen Handling
5
Standard of Care
4
Practice Guidelines as Topic
4
Magnetic Resonance Spectroscopy
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Melphalan
3
Interviews as Topic
3
GSK2636771
3
Cyclophosphamide
3
Crizotinib
3
Busulfan
3
Biopsy
3
Antilymphocyte Serum
3
AP 1903 reagent
3
venetoclax
2
thymoglobulin
2
palbociclib
2
osimertinib
2
letermovir
2
dabrafenib
2
capivasertib
2
binimetinib
2
adavosertib
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Hematologic Neoplasms
×
Behavior Therapy
×
Clear all
NCT04829539
2026-04-24
BBT-II
University of Rochester
Phase 3
Active not recruiting
400 enrolled
NCT05075759
2026-04-16
SALSA
Fred Hutchinson Cancer Center
Phase NA
Active not recruiting
374 enrolled